Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03513419 · ClinicalTrials.gov registry record · NA
The AMOR Method: Resilience Training for Parents of Children With Autism
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT03513419: Completed NA study, sponsored by Stanford University.
NCT03513419 is a NA study that has completed, run by Stanford University. The registered enrollment target is 36 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03513419, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
We will evaluate whether a resilience training program which includes group and individual parent training will be effective in improving optimism and resiliency in parents of young children with autism spectrum disorders (ASD). By observing the level of parent optimism and resiliency before and after intervention, we will be able to determine whether the intervention is effective in improving parent resilience.
Primary Outcome
No subscales, total score only, 25 items total, 0-4 Likert Score Range: 0-100 Low resilience score (PTSD \& grief populations) = 45 or lower; Average/Normal resilience score (general population) = 45-80; High Average/Elevated resilience score (yogi \& meditation teachers) = 81-100 Higher total scores reflect higher levels of resilience.
Interventions
- BEHAVIORAL The AMOR Method
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2018-05-25 |
| Est. Completion | 2020-02-29 |
| Phase | NA |
What the finished NCT03513419 record still lists
NCT03513419 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which The AMOR Method is the first listed.
NCT03513419 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03513419 about?
NCT03513419 is a clinical study titled "The AMOR Method: Resilience Training for Parents of Children With Autism". We will evaluate whether a resilience training program which includes group and individual parent training will be effective in improving optimism and resiliency in parents of young children with autism spectrum disorders (ASD). By observing the level of parent optimism and resiliency before and aft...
What is the current status of trial NCT03513419?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2018-05-25. Estimated completion is 2020-02-29.
What interventions are being tested in trial NCT03513419?
The interventions under investigation include: The AMOR Method (BEHAVIORAL).
Who is sponsoring clinical trial NCT03513419?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03513419's enrollment target sits among peer trials
36 1541st of 2000 higher than 437 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI